This article was published in Multiple Sclerosis News Toady dated April 21, 2016.

Can there be hope that somewhere in the near future this debilitating dis-ease will be cured?

Mabthera (rituximab), a widely approved drug for treating lymphoma and/or rheumatoid arthritis, is highly effective in treating multiple sclerosis (MS), researchers reported in an observational study in Sweden, where Mabthera is increasingly being used outside of its approved indications to treat relapsing-remitting MS patients. The study, published in the journal read more